Systemic Sclerosis: From Pathogenesis Towards Targeted Immunotherapies

Publisher： Bentham Science Publishers

E-ISSN： 1875-6360|8|1|45-55

ISSN： 1573-3971

Source： Current Rheumatology Reviews, Vol.8, Iss.1, 2012-02, pp. : 45-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urotensin-II in systemic sclerosis: a new peptide in pathogenesis

By Pehlivan Yavuz   Onat Ahmet   Comez Gazi   Babacan Taner  

Clinical Rheumatology, Vol. 30, Iss. 6, 2011-06 ,pp. : 837-842

Springer Publishing Company

Access to resources Recommend Favorite

The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis

By Pauling J. D.   O’Donnell V. B.   Mchugh N. J.  

Platelets, Vol. 24, Iss. 7, 2013-11 ,pp. : 503-515

Informa Healthcare

Access to resources Recommend Favorite

Autophagy is a key feature in the pathogenesis of systemic sclerosis

By Frech Tracy   Domenico Ivana   Murtaugh Maureen   Revelo Monica   Li Dean   Sawitzke Allen   Drakos Stavros  

Rheumatology International, Vol. 34, Iss. 3, 2014-03 ,pp. : 435-439

Springer Publishing Company

Access to resources Recommend Favorite

Role of Growth Factors in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis

By  

Current Rheumatology Reviews, Vol. 6, Iss. 4, 2010-11 ,pp. : 283-294

Bentham Science Publishers

Access to resources Recommend Favorite

Safety of intravenous methylprednisolone therapy in patients suffering from systemic sclerosis

By Vanthuyne M   Depresseux G   Houssiau FA  

Scandinavian Journal of Rheumatology, Vol. 39, Iss. 2, 2010-03 ,pp. : 178-179

Informa Healthcare

Access to resources Recommend Favorite